Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis

6 Dec 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asthma and respiratory diseases
Share to Autoimmune Bullous Skin Diseases
Share to Mast cells and histamine

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25582384
DOI: 10.1016/j.leukres.2014.11.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of sensitive KIT D816V detection on recognition of Indolent Systemic MastocytosisPMID 25582384Read ↗

Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR AssaySemantic proximity Read ↗

Detection of KIT Mutations in Systemic Mastocytosis: How, When, and Why.Semantic proximity Read ↗

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.Semantic proximity Read ↗

Systemic mastocytosis for the practicing clinician: overview, diagnostic features, prognostication and antiproliferative treatment in the era of targeted therapy.Semantic proximity Read ↗

How we diagnose and treat systemic mastocytosis in adults.Semantic proximity Read ↗

Detection of C-KIT Mutations in Systemic Mastocytosis: How, When and WhySemantic proximity Read ↗

KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis.Semantic proximity Read ↗

Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.Semantic proximity Read ↗

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes.Semantic proximity Read ↗

Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression.Semantic proximity Read ↗

Targeted therapy in KITD816V-positive mastocytosis: waiting for proof-of-principle.Semantic proximity Read ↗

Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.